| Global Market Size | $600MAddressable ETFA |
|---|---|
| Market Cap | ₹14276 CrMid-cap |
| Revenue TTM | ₹2365 CrOperating |
| RSI | 36.05Technical |
Key highlights
- First global commercialisation of ETFA using continuous flow chemistry technology
- Targets a global addressable market for ETFA estimated at USD 500 to 600 million
- ETFA serves as a critical fluorinated building block for life sciences and performance materials
- Continuous flow platform provides superior process safety and operational efficiency over batch processes
- Product launched across multiple international markets including the USA and Japan
The Product — What It Is
Ethyl trifluoroacetate, commonly known as ETFA, is a critical fluorinated building block and reagent essential for synthesizing a diverse range of organic fluorine compounds. These compounds are integral to modern life sciences, pharmaceuticals, and performance materials industries. Fluorine chemistry is valued for its ability to enhance product performance, efficacy, and stability in complex chemical structures.
By utilizing its proprietary process-by-design continuous flow chemistry platform, Anupam Rasayan is moving away from traditional batch processes. This transition ensures enhanced process safety, superior reproducibility, and improved scalability, while significantly reducing the environmental footprint of the chemical manufacturing process.
Commercial Opportunity
- The global addressable market for ETFA is currently estimated to be worth between USD 500 million and USD 600 million
- Anupam Rasayan becomes the first company globally to achieve commercial-scale production using flow technology
- The product will cater to both domestic and international markets, including high-demand regions like the USA and Japan
- Flow chemistry allows for higher operational efficiency, providing a competitive edge in pricing and volume stability
- This launch addresses evolving customer requirements for differentiated manufacturing solutions in the specialty chemicals value chain
Technological Achievement
The successful commercialisation of ETFA through our continuous flow chemistry platform represents a significant milestone in Anupam Rasayan's innovation journey. This achievement not only demonstrates our technological capabilities in complex fluorination chemistry but also highlights our ability to develop and scale differentiated manufacturing solutions that address evolving customer requirements.
Business Overview
Anupam Rasayan India Limited is a leading player in the custom synthesis and manufacturing of specialty chemicals in India. Established in 1984, the company operates across two primary verticals: Life Science related Specialty Chemicals and Performance Materials. Its product portfolio supports industries ranging from agrochemicals and pharmaceuticals to electronics and EV chemicals.
The company manages eight manufacturing facilities with a combined aggregate installed capacity of approximately 66,000 MT. This includes four sites in Surat, two in Jhagadia, and two facilities in the USA operated via Jayhawk Fine Chemicals. As of March 2026, the company serves over 75 domestic and international customers, including 31 multinational corporations.
| Share price | ₹1254 |
|---|---|
| Market capitalisation | ₹14,276.58 Cr |
| Revenue (annual) | ₹2,365.46 Cr |
| Net profit (annual) | ₹170.12 Cr |
| Revenue (latest quarter) | ₹635.78 Cr+24.07% vs previous quarter |
| Net profit (latest quarter) | ₹42.65 Cr-13.03% vs previous quarter |
| P/E (TTM) | 83.92×Sector 42.44× |
| Promoter holding | 59.07%0.00% QoQ |
| FII holding | 6.91%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Anupam Rasayan India Ltd announcing the commercialisation of ETFA using flow chemistry technology. Market figures from a third-party data provider.
